PRKCE and metabolic dysfunction-associated steatotic liver disease: From the perspective of IR, mTOR regulates IRS1, Lipin1, Foxo1, PKCε, and other important targets related to IR and plays a key role in the development of IR by affecting insulin production, thus blocking the progression of NAFLD.